Ryvent Tablet
Product Images NDC 15370-130

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ryvent (NDC 15370-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carwin Pharmaceutical Associates, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbinoxamine Maleate Chemical Structure (13ed76c7 49bd 4527 83dc B4c7d0da9fff 01)

Chemical structure of carbinoxamine maleate, showing the molecular arrangement of the active ingredient carbinoxamine combined with maleate.*

FDA Label Image

Container Label (13ed76c7 49bd 4527 83dc B4c7d0da9fff 02)

Label for RyVent 6 mg tablets, containing carbinoxamine maleate. The container holds 100 tablets. The label includes storage instructions and states that the product is prescription only. It is manufactured by Carwin Pharmaceutical Associates, LLC, Hazlet, NJ. The NDC on the label is 15370-130-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.